SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-16-012425
Filing Date
2016-04-12
Accepted
2016-04-12 16:02:25
Documents
3
Period of Report
2016-04-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k041216_oxysuretherap.htm 8-K 26824
2 AS CORRECTED CERTIFICATE OF AMENDMENT, FILED APRIL 6, 2016, TO THE COMPANY'S ART f8k041216ex3i_oxysure.htm EX-3.1 10636
3 AS CORRECTED CERTIFICATE OF AMENDMENT, FILED APRIL 4, 2016, TO THE COMPANY'S ART f8k041216ex3ii_oxysure.htm EX-3.2 6778
  Complete submission text file 0001213900-16-012425.txt   45495
Mailing Address 10880 JOHN W. ELLIOTT ROAD SUITE 600 Frisco TX 75034
Business Address 10880 JOHN W. ELLIOTT ROAD SUITE 600 Frisco TX 75034 (972) 294-6450
OxySure Therapeutics, Inc. (Filer) CIK: 0001413797 (see all company filings)

IRS No.: 710960725 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54137 | Film No.: 161567283
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10